Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Capital Expenditures Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Capital Expenditures
-AU$129.3k
CAGR 3-Years
37%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Capital Expenditures
-AU$20.9m
CAGR 3-Years
6%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Capital Expenditures
-AU$25k
CAGR 3-Years
-46%
CAGR 5-Years
-16%
CAGR 10-Years
5%
Botanix Pharmaceuticals Ltd
ASX:BOT
Capital Expenditures
-AU$18m
CAGR 3-Years
-1 195%
CAGR 5-Years
-323%
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Capital Expenditures
-AU$10.8m
CAGR 3-Years
-47%
CAGR 5-Years
0%
CAGR 10-Years
-5%
Vita Life Sciences Ltd
ASX:VLS
Capital Expenditures
-AU$583k
CAGR 3-Years
-64%
CAGR 5-Years
-72%
CAGR 10-Years
2%

See Also

What is Arovella Therapeutics Ltd's Capital Expenditures?
Capital Expenditures
-129.3k AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Capital Expenditures amounts to -129.3k AUD.

What is Arovella Therapeutics Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
38%

Over the last year, the Capital Expenditures growth was -4 655%. The average annual Capital Expenditures growth rates for Arovella Therapeutics Ltd have been 37% over the past three years , 38% over the past five years .

Back to Top